...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith cost basis

Two different brokerages.  Two different numbers and neither is the same as yours. 

 It's a waste of time asking your brokerage.  If you really want to know, ask the folks at Zenith.  If we ever have shares to sell, they will provide a tax document to prove the cost basis, as they did for RVX.

 

 

Share
New Message
Please login to post a reply